Back

Plasma apelin levels in pulmonary arterial hypertension: a potential early diagnostic biomarker?

29 August 2026 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Pulmonary hypertension: pathophysiology and mechanisms Pulmonary Hypertension ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Cagatay Tunca

Ankara Etlik City Hospital, Ankara (Turkiye)

7 More presentations in this session

Presentation thumbnail
Exploratory study on the inhibitory effect of dihydrotanshinone on RNA-binding protein (HuR) in the treatment of pulmonary heart disease with right ventricular fibrosis
Professor X. Yu (Guangzhou, CN)
Abstract Slides Video
Presentation thumbnail
Multi-omics interrogation of energy metabolism reveals novel causal targets in pulmonary arterial hypertension
Mr S. Hou (Shanghai, CN)
Abstract Slides Video
Presentation thumbnail
Cardiovascular and metabolic comorbidities shape endothelial dysfunction in pulmonary arterial hypertension and may influence treatment: insights from a multicenter translational network
Associate Professor R. Madonna (Pisa, IT)
Abstract Slides Video
Presentation thumbnail
CCR6⁺ T cells as potential drivers of inflammation in chronic thromboembolic pulmonary hypertension
Miss C. Ferreira (Coimbra, PT)
Abstract Slides Video
Presentation thumbnail
Peripheral T-cell remodeling in long-standing PAH: CD4+ reduction and CCR6 enrichment
Miss C. Ferreira (Coimbra, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Pulmonary hypertension: pathophysiology and mechanisms

The Event

Event poster

ESC Congress 2026

29 August 2026 11:15 CET
You may be interested in
thumbnail
Congress Session
Pulmonary hypertension: advanced diagnostics
30 August 2024
thumbnail
Congress Presentation
High apelin levels post-STEMI predict increased risk of adverse outcomes: insights from the INFINITY study
1 September 2025
thumbnail
Congress Presentation
A real-world study on selexipag for pulmonary arterial hypertension: a single-center retrospective study
29 August 2025
thumbnail
Congress Presentation
CTRP7 as a molecular biomarker for predicting responsiveness to pulmonary vasodilators: insights from human and animal studies in pulmonary arterial hypertension.
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources